The effectiveness and limitations of regulatory warnings for the safe prescribing of citalopram
Kevin J Friesen, Shawn C BugdenFaculty of Health Sciences, College of Pharmacy, University of Manitoba, Winnipeg, MB, CanadaBackground: Citalopram is the most commonly prescribed antidepressant in Canada. Concerns have been raised about its cardiac safety, and a dose-dependent prolongation of the QT...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-08-01
|
Series: | Drug, Healthcare and Patient Safety |
Online Access: | http://www.dovepress.com/the-effectiveness-and-limitations-of-regulatory-warnings-for-the-safe--peer-reviewed-article-DHPS |